Daniel Tillett
Patrimonio netto: 38 M $ in data 31/05/2026
Patrimonio netto: 38 M $ in data 31/05/2026
Dr. Daniel Tillett is a Chief Executive Officer, MD & Director at Racura Oncology Ltd. He is on the Board of Directors at Entropy Neurodynamics Ltd. and Racura Oncology Ltd. Dr. Tillett was previously employed as a Non-Executive Director by Simble Solutions Ltd., an Executive Director & Chief Scientific Officer by Race Oncology Ltd., and a Chief Executive Officer by Nucleics Ltd. He received his undergraduate degree from School of Biotechnology & Biomolecular Sciences and a doctorate degree from School of Biotechnology & Biomolecular Sciences.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
RACURA ONCOLOGY LTD 10,64% | 28/05/2026 | 20.269.351 ( 10,64% ) | 38 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RACURA ONCOLOGY LTD | Amministratore Delegato | 22/11/2023 |
| Società | Posizione | Fine |
|---|---|---|
| SIMBLE SOLUTIONS LIMITED | Direttore/Membro del Consiglio | 03/07/2023 |
| RACURA ONCOLOGY LTD | Direttore Tecnico/Scientifico/R&S | 23/03/2023 |
Nucleics Ltd. | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Race Oncology Ltd.
Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Simble Solutions Ltd.
Simble Solutions Ltd. Packaged SoftwareTechnology Services Develops software for enterprises to manage business and resources | Technology Services |
School of Biotechnology & Biomolecular Sciences
School of Biotechnology & Biomolecular Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nucleics Ltd. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale